Activation of platelet protein kinase C by ultraviolet light B mediates platelet transfusion-related acute lung injury in a two-event animal model

Transfusion

Volumn 53, Issue 4, 2013, Pages 722-731

  Zhi, Li ^a   Chi, Xuan ^a   Gelderman, Monique P ^a   Vostal, Jaroslav G ^a  

^a not available   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; FIBRINOGEN; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; PROTEIN KINASE C;

ADVERSE OUTCOME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING KINETICS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IN VITRO STUDY; LUNG LAVAGE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; RADIATION EXPOSURE; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE POOR PLASMA; THROMBOCYTE TRANSFUSION; TRANSFUSION RELATED ACUTE LUNG INJURY; ULTRAVIOLET B RADIATION;

EID: 84876134168     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03811.x     Document Type: Article

References (37)

1. Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM, McFarland JG, Nathens AB, Silliman CC, Stroncek D,. Transfusion-related acute lung injury: definition and review. Crit Care Med 2005; 33: 721-6.
2. Vamvakas EC, Blajchman MA,. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009; 113: 3406-17.
3. Gajic O, Rana R, Winters JL, Yilmaz M, Mendez JL, Rickman OB, O'Byrne MM, Evenson LK, Malinchoc M, DeGoey SR, Afessa B, Hubmayr RD, Moore SB,. Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med 2007; 176: 886-91.
4. Wallis JP, Sachs UJ,. Rossi's principles of transfusion medicine. Bethesda (MD): American Association of Blood Banks; 2009.
5. Wallis JP,. Transfusion-related acute lung injury (TRALI)-under-diagnosed and under-reported. Br J Anaesth 2003; 90: 573-6.
6. Silliman CC, Boshkov LK, Mehdizadehkashi Z, Elzi DJ, Dickey WO, Podlosky L, Clarke G, Ambruso DR,. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003; 101: 454-62.
7. Silliman CC, Paterson AJ, Dickey WO, Stroneck DF, Popovsky MA, Caldwell SA, Ambruso DR,. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 1997; 37: 719-26.
8. Godzich M, Hodnett M, Frank JA, Su G, Pespeni M, Angel A, Howard MB, Matthay MA, Pittet JF,. Activation of the stress protein response prevents the development of pulmonary edema by inhibiting VEGF cell signaling in a model of lung ischemia-reperfusion injury in rats. FASEB J 2006; 20: 1519-21.
9. Frank JA, Gutierrez JA, Jones KD, Allen L, Dobbs L, Matthay MA,. Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs. Am J Respir Crit Care Med 2002; 165: 242-9.
10. Altemeier WA, Matute-Bello G, Gharib SA, Glenny RW, Martin TR, Liles WC,. Modulation of lipopolysaccharide-induced gene transcription and promotion of lung injury by mechanical ventilation. J Immunol 2005; 175: 3369-76.
11. Zarbock A, Singbartl K, Ley K,. Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest 2006; 116: 3211-9.
12. Looney MR, Su X, Van Ziffle JA, Lowell CA, Matthay MA,. Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest 2006; 116: 1615-23.
13. Looney MR, Nguyen JX, Hu Y, Van Ziffle JA, Lowell CA, Matthay MA,. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest 2009; 119: 3450-61.
14. Piper JT, Gelderman MP, Vostal JG,. In vivo recovery of human platelets in severe combined immunodeficient mice as a measure of platelet damage. Transfusion 2007; 47: 1540-9.
15. Gelderman MP, Chi X, Zhi L, Vostal JG,. Ultraviolet B light-exposed human platelets mediate acute lung injury in a two-event mouse model of transfusion. Transfusion 2011; 51: 2343-57.
16. Snyder E, McCullough J, Slichter SJ, Strauss RG, Lopez-Plaza I, Lin J-S, Corash L, Conlan MG,. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial. Transfusion 2005; 45: 1864-75.
17. Cazenave JP, Folléa G, Bardiaux L, Boiron JM, Lafeuillade B, Debost M, Lioure B, Harousseau JL, Tabrizi R, Cahn JY, Michallet M, Ambruso D, Schots R, Tissot JD, Sensebé L, Kondo T, McCullough J, Rebulla P, Escolar G, Mintz P, Heddle NM, Goodrich RP, Bruhwyler J, Le C, Cook RJ, Stouch B,; for members of the Mirasol Clinical Evaluation Study Group. A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology. Transfusion 2010; 50: 2362-75.
18. van Marwijk Kooy M, Akkerman JW, van Asbeck S, Borghuis L, van Prooijen HC,. UVB radiation exposes fibrinogen binding sites on platelets by activating protein kinase C via reactive oxygen species. Br J Haematol 1993; 83: 253-8.
19. Bertrand ME, Rupprecht H-J, Urban P, Gershlick AH,; Investigators ftC. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 2000; 102: 624-9.
20. Stolla M, Stefanini L, André P, Ouellette TD, Reilly MP, McKenzie SE, Bergmeier W,. CalDAG-GEFI deficiency protects mice in a novel model of FcγRIIA-mediated thrombosis and thrombocytopenia. Blood 2011; 118: 1113-20.
21. Tam SH, Sassoli PM, Jordan RE, Nakada MT,. Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and alpha(v)beta3 integrins. Circulation 1998; 98: 1085-91.
22. Shattil SJ, Hoxie JA, Cunningham M, Brass LF,. Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. J Biol Chem 1985; 260: 11107-14.
23. Strehl A, Munnix IC, Kuijpers MJ, van der Meijden PE, Cosemans JM, Feijge MA, Nieswandt B, Heemskerk JW,. Dual role of platelet protein kinase C in thrombus formation: stimulation of pro-aggregatory and suppression of procoagulant activity in platelets. J Biol Chem 2007; 282: 7046-55.
24. Tekamp-Olson P, Gallegos C, Bauer D, McClain J, Sherry B, Fabre M, van Deventer S, Cerami A,. Cloning and characterization of cDNAs for murine macrophage inflammatory protein 2 and its human homologues. J Exp Med 1990; 172: 911-9.
25. Rahman M, Zhang S, Chew M, Ersson A, Jeppsson B, Thorlacius H,. Platelet-derived CD40L (CD154) mediates neutrophil upregulation of Mac-1 and recruitment in septic lung injury. Ann Surg 2009; 250: 783-90.
26. Reverter JC, Beguin S, Kessels H, Kumar R, Hemker HC, Coller BS,. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis." J Clin Invest 1996; 98: 863-74.
27. Jantzen H-M, Milstone DS, Gousset L, Conley PB, Mortensen RM,. Impaired activation of murine platelets lacking Gαi2. J Clin Invest 2001; 108: 477-83.
28. Quinton TM, Kim S, Dangelmaier C, Dorsam RT, Jin J, Daniel JL, Kunapuli JL,. Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation. Biochem J 2002; 368: 535-43.
29. Cifuni SM, Wagner DD, Bergmeier W,. CalDAG-GEFI and protein kinase C represent alternative pathways leading to activation of integrin αIIbβ3 in platelets. Blood 2008; 112: 1696-703.
30. Clark RA, Klebanoff SJ,. Neutrophil-platelet interaction mediated by myeloperoxidase and hydrogen peroxide. J Immunol 1980; 124: 399-405.
31. Parise LV, Criss AB, Nannizzi L, Wardell MR,. Glycoprotein IIIa is phosphorylated in intact human platelets. Blood 1990; 75: 2363-8.
32. Magallon J, Chen J, Rabbani L, Dangas G, Yang J, Bussel J, Diacovo T,. Humanized mouse model of thrombosis is predictive of the clinical efficacy of antiplatelet agents. Circulation 2011; 123: 319-26.
33. The CAPTURE Investigators. Randomized placebo-controlled trial of abciximab before and during intervention in refractory unstable angina: the CAPTURE study. Lancet 1997; 349: 1429-35.
34. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockage and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997; 336: 1689-96.
35. Weber C, Springer TA,. Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor. J Clin Invest 1997; 100: 2085-93.
36. Silliman CC, Fung YL, Bradley Ball J, Khan SY,. Transfusion-related acute lung injury (TRALI): current concepts and misconceptions. Blood Rev 2009; 23: 245-55.
37. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997; 337: 1861-70.